Latest News & Updates
Breaking News
2 hours ago
Vaibhavi M.
Other trending news you may like to read
Ocugen Completes Dosing In Phase 2/3 GARDian3 Trial For Stargardt Gene Therapy, Moves Toward BLA Filing After Successful Trial Progress
Ocugen, Inc. completes dosing in Phase 2/3 GARDian3 trial of OCU410ST for Stargardt disease, advancing its gene therapy toward planned BLA submission after positive progress.
Vaibhavi M.
Vertex Expands FDA Approval For ALYFTREK And TRIKAFTA In Cystic Fibrosis, Broadens Access Covering 95% Of Patients
Vertex Pharmaceuticals Incorporated expands FDA approval for ALYFTREK and TRIKAFTA, enabling broader treatment of cystic fibrosis across more CFTR variants and younger patient populations.
Vaibhavi M.
Thermo Fisher Introduces Integrated Cell Line Platform; CHOvantage GS Platform For Faster, Scalable Biologics Development
Thermo Fisher Scientific Inc. launches CHOvantage GS platform to accelerate biologics development, enabling high-yield CHO cell line creation with faster timelines and scalable manufacturing support.
Vaibhavi M.
Lilly Secures FDA Approval For Foundayo With Strong Trial Results, Expanding Oral Treatment Options For Obesity
Eli Lilly and Company gains FDA approval for Foundayo (orforglipron), an oral drug for obesity, showing significant weight loss in trials and expanding treatment access options.
Vaibhavi M.
